Evaluating Disparities in Precision Oncology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIndiana University
About this trial
This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
Eligibility criteria
Qualifiers
Ability to provide written informed consent and HIPAA authorization
Patients must be ≥ 18 years old at the time of consent
Patients who have or are planning to undergo molecular testing as part of their routine cancer care
Disqualifiers
None
Trial design
Treatments tested in this trial
- Social Determinants of Health and toxicity questionnaires
Treatment groups
10,600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov